A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Clinical trial NCT01878617 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01878617
- Sponsor
- St. Jude Children's Research Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-23
- Primary completion
- 2028-10-13
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.